PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 22733815-1 2012 FGFs 19, 21, and 23 are hormones that regulate in a Klotho co-receptor-dependent fashion major metabolic processes such as glucose and lipid metabolism (FGF21) and phosphate and vitamin D homeostasis (FGF23). Glucose 123-130 klotho Homo sapiens 52-58 23941507-9 2013 Plasma alpha-klotho levels had a significantly negative correlation with fasting glucose levels (r=-0.216, p=0.018) and mean IMT (r=-0.258, p=0.004) in multiple stepwise regression analyses. Glucose 81-88 klotho Homo sapiens 13-19 29884183-14 2018 CONCLUSIONS: Taken together, KL is a negative regulator of aerobic glycolysis and KL inhibited glucose metabolism transformation via the ERK/ HIF1alpha axis. Glucose 95-102 klotho Homo sapiens 82-84 21695423-2 2012 KL participates to the regulation of a number of intracellular biochemical pathways, including lipid profile and glucose metabolism. Glucose 113-120 klotho Homo sapiens 0-2 21695423-6 2012 Gender-segregated analyses confirmed these associations, and suggested that the associations of KL genotypes with HDL-C, fasting glucose and fasting insulin levels may be driven by the female gender, while the association with serum levels of hemoglobin may be driven by the male gender. Glucose 129-136 klotho Homo sapiens 96-98 21695423-8 2012 The genetic risk score (GRS) models further confirmed significant associations among KL SNPs and hemoglobin, total cholesterol, and HDL-C. Gender-segregated analyses with the GRS-tagged approach confirmed the associations with HDL-C, fasting glucose, and fasting insulin levels in females, and with hemoglobin and LC in males. Glucose 242-249 klotho Homo sapiens 85-87 21695423-9 2012 Our findings suggested that KL locus may influence quantitative traits such as serum levels of lipid, fasting glucose, albumin and hemoglobin in hospitalized older patients, with some gender differences suggested for creatinine, IGF-1 levels, and LC, thus being one of the genetic factors possibly contributing to age-related diseases and longevity. Glucose 110-117 klotho Homo sapiens 28-30 34967938-8 2021 Glucose uptake and lactate production in the cardiomyocytes subjected to I/R were normalized after Klotho supplementation. Glucose 0-7 klotho Homo sapiens 99-105 30697600-10 2019 Moreover, an oral glucose tolerance test revealed that soluble Klotho levels decreased, whereas a paradoxical GH peak was observed after glucose intake in a patient with GHoma. Glucose 18-25 klotho Homo sapiens 63-69 30042059-6 2018 Moreover, decreases in alpha-Klotho and beta-Klotho levels in the high glucose-exposed cell culture model, which was dependent on glucose exposure time, were confirmed. Glucose 71-78 klotho Homo sapiens 29-35 30042059-6 2018 Moreover, decreases in alpha-Klotho and beta-Klotho levels in the high glucose-exposed cell culture model, which was dependent on glucose exposure time, were confirmed. Glucose 130-137 klotho Homo sapiens 29-35 29884183-8 2018 The impact of KL on glucose metabolism and its mechanisms were further validated in vitro and in vivo. Glucose 20-27 klotho Homo sapiens 14-16 30620382-5 2018 Because FGF23/Klotho system affects glucose metabolism and gene expression of antioxidant enzymes, changes in its concentration may be a marker of chronic complications of diabetes or a treatment option. Glucose 36-43 klotho Homo sapiens 14-20 27916483-7 2017 Multiple linear regression analyses revealed that alpha-Klotho and beta-Klotho levels were positively correlated with the creatinine clearance rate, and negatively correlated with the urinary albumin to creatinine ratio and randomly sampled serum levels of creatinine, blood urea nitrogen, and blood glucose. Glucose 300-307 klotho Homo sapiens 56-62 28411025-0 2017 Klotho down-regulates Egr-1 by inhibiting TGF-beta1/Smad3 signaling in high glucose treated human mesangial cells. Glucose 76-83 klotho Homo sapiens 0-6 28411025-8 2017 High glucose time-dependently down-regulated Klotho mRNA and protein expression in cultured human MCs. Glucose 5-12 klotho Homo sapiens 45-51 28411025-12 2017 Klotho overexpression can prevent mesangial ECM production in high-glucose-treated human MCs, an effect that has been partially attributed to Egr-1 down-regulation facilitated by TGF-beta1/Smad3 signaling inhibition. Glucose 67-74 klotho Homo sapiens 0-6 26806457-0 2016 Effect of systemically increasing human full-length Klotho on glucose metabolism in db/db mice. Glucose 62-69 klotho Homo sapiens 52-58 26806457-3 2016 Increasing the full-length human Klotho levels has a positive effect on blood glucose through increasing insulin secretion. Glucose 78-85 klotho Homo sapiens 33-39